04/29/2025 8:11 PM | Iterum Therapeutics (Filer)
| Form 424B5 | |
04/29/2025 8:16 PM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2025 7:00 AM | Iterum Therapeutics (Issuer) Whalen Joseph John (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/10/2025 7:35 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2025 11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
02/14/2025 4:36 PM | ARMISTICE CAPITAL, LLC (Filed by) Iterum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025 3:33 PM | Iterum Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/07/2025 6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2025 6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
01/23/2025 5:30 PM | HUNT RONALD (Reporting) Iterum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2024 5:30 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ITRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
12/10/2024 6:04 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
11/21/2024 8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:54 PM | Iterum Therapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024 5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024 10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 7:00 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2024 4:20 PM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 3:15 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/30/2024 6:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024 7:59 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024 8:01 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/23/2024 5:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/11/2024 3:50 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/09/2024 5:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
08/14/2024 6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
08/12/2024 8:00 AM | HUNT RONALD (Reporting) Iterum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 8:00 AM | Fishman Corey N. (Reporting) Iterum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 8:00 AM | Dunne Michael W. (Reporting) Iterum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 4:28 PM | Iterum Therapeutics (Filer)
| Form POS AM | |
08/06/2024 4:25 PM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2024 3:30 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/22/2024 7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2024 11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
Musk's warning signal: Prepare before the cascade begins (Ad) When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t.
With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now. Watch the Musk market warning before the dominoes fall |
07/19/2024 4:05 PM | Iterum Therapeutics (Filer)
| Form 424B3 | |
07/17/2024 3:21 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/26/2024 4:24 PM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2024 4:27 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/21/2024 7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 3:11 PM | Iterum Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/31/2024 7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |